Article · 31 Jul 2024
Research articlePublished 21 Sep 2018
Treating Symptoms of Morning Sickness: The First Dual Release Combination of Doxylamine-Pyridoxine
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Modified release tablet preparations are sought when there is a need to provide clinical solutions which are not achieved optimally with the standard release products. Nausea and vomiting of pregnancy (NVP) affect most pregnancies. Symptomatic treatment aims to improve woman’s quality of life, and counteract dehydration, electrolyte imbalance, need for hospitalization and attendant risk of maternal and fetal complications. Until recently, the only agent approved by Canada, USA, South Korea. Israel and Singapore has been the delayed release combination of doxylamine and pyridoxine (Diclectin®/ Diclegis®). All other countries worldwide do not presently have a pregnancy- approved anti emetic drug. Due to its delayed release properties, Diclectin®/ Diclegis® begins to exert its antiemetic effect 6-8 hours after ingestion, and hence symptom relief may be delayed and necessitate the use of an immediate release medication. In November 2016 the FDA approved Bonjesta®, a novel, dual- release combination of doxylamine and pyridoxine, whereby a rapid release phase is followed by a delayed release phase, thus overcoming the time delay in action of the delayed release combination of doxylamine and pyridoxine. In this article we review the unique properties of this new drug in the context of other medications where modified- release forms have been effective.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in International Journal of Pharmacy.
Article · 31 Jul 2024
Bridging Genetics and Pharmacology for Personalized Treatment through Pharmacogenomics
Article · 31 Jul 2024
The Impact of Pharmacotherapy on Well-Being of Modern Health Care
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Pharmacy
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Gideon Koren”
- BylineArticles whose byline prints “Manon Vrandrick”